← Back to Influence Map
Entity DossierOrganization
ASSOCIATION FOR CLINICAL ONCOLOGY
VA · US
pharmaceuticals
Tracked direct giving
$0
LDA reported lobbying spend
$2,600,000
Connections
5
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
HCRHealth Issues
$4.5MBUDBudget/Appropriations
$3.8MMMMMedicare/Medicaid
$3.6MTOBTobacco
$2.8MLobbying Firms Retained
In-house lobbyists (filed as its own registrant)$3.6M
TIBER CREEK GROUP$900K
Bills Referenced in Lobbying Filings
PBMprior authorization
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Commented on | Centers for Medicare & Medicaid Services | Public comment on CMS-2023-0127: Request for Information: Episode-based Payment Model | Source |
| Lobbied on | Pharmacy Benefit Manager Reform Act | LDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $250,000 | Source |
| Lobbied on | Prior Authorization Reform (Improving Seniors Timely Access to Care Act) | LDA filing: lobbied on Prior Authorization Reform, period 1st Quarter (Jan 1 - Mar 31), reported amount $190,000 | Source |
| Commented on | Department of Health and Human Services | Public comment on HHS-ONC-2024-0010: Health Data, Technology, and Interoperability: Patient Engagement, Information Sharing, and Public HealthInteroperability | Source |
| Retained | TIBER CREEK GROUP | Hired TIBER CREEK GROUP to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |